Youtor
FLASH Radiotherapy What we know and where we need to go
>> YOUR LINK HERE: ___ http://youtube.com/watch?v=KSX7KHtEVAo
The webinar is intended to provide a backdrop of the current FLASH landscape - from the important beam parameters, to radiochemical consideration and how those influence biological models and potential clinical applications. Recent advances will be discussed and a road-map will be provided highlighting key areas that need further development. • Learning Objectives: • 1. What the critical beam parameters are that require optimization • 2. Some radiation chemistry and redox biology that are likely to be important • 3. How the FLASH effect is defined • 4. How FLASH radiotherapy has been applied in multiple preclinical and clinical models • 5. The pros and cons of different beam modalities • 6. Key questions that remain unresolved - YES - even some potential research applications for those interested in this field! • Find the supplementary Q A Session here: • *Answer Session* FLASH Radiotherapy: ... • About Dr. Limoli: • Dr. Limoli received his BS degree in chemistry from MIT then went on to receive his PhD in Biomedical Sciences from UCSD. Following a postdoc at UCSF, he received his first academic appointment at that institute where he stayed for 12 years before going to UCI in 2006. • Since that time Dr. Limoli’s research has focused on radiation effects in the CNS, where he has defined many of the mechanisms that contribute to radiation-induced cognitive dysfunction. His work has since defined the importance of oxidative stress in the brain, how irradiation disrupts neuronal structure and synaptic integrity and how stem cells can be used to offset the adverse effects of both radio- and chemotherapy in the brain. • Continued work strives to further understand the causes, consequences and potential remedies for neurocognitive dysfunction caused by various cancer treatments. Dr. Limoli is a professor in the Department of Radiation Oncology at the University of California Irvine. • About Dr. Vozenin • Dr. Vozenin heads the Radiobiology laboratory of Universite de Lausanne (CHUV), Oncology Department, Switzerland. Since past few years, Dr. Vozenin has led on the innovative research in the field of radiation therapy for the treatment of cancers. • Dr. Vozenin’s group have pioneered in developing novel ultra-high dose rate radiation delivery modality (FLASH). Using FLASH irradiation, her recent path-breaking work has shown selective tumor kill efficacy with protective effects on the normal tissue including perivascular and CNS. • As a result, Dr. Vozenin’s research has laid the foundation for developing new FLASH-based cancer treatment modality that allows complete eradication of tumors as well as reduced occurrence and severity of early and late complications affecting the normal tissue. • Dr. Vozenin’s laboratory is funded by the French National Research Agency (FNS/ANR) and the Swiss National Science Foundation (SNSF) grants.
#############################
